Search

The inventor of the World Wide Web, Sir Tim Berners-Lee, unveiled a new body with a mission to maintain a single, free and open Web.

The charity Cancer Research UK confirmed its position as the largest single investor in R&D in the field, announcing it spent a record £333 million on research in its last financial year.

A report by the self-styled, ‘International Expert Group on Biotechnology, Innovation And Intellectual Property’ says a new era is opening for intellectual property (IP).

Europe’s answer to the innovation powerhouse of MIT finally gets off the ground. Now it needs corporate support, says Barroso.

Commission President José Manuel Barroso is convinced that the EIT can play a major role in making Europe tomorrow’s magnet for talent.

Boston Scientific, a specialist in medical devices for minimally invasive surgical procedures, is to invest €50 million in R&D at its facility in Galway, Ireland.

Bosch, DuPont and Xerox Corporation have joined a business-inspired movement to put environmentally important IP into the public domain.

The Commission this week published a new guide to help users of European research, innovation and cohesion funding – the “Practical Guide to EU funding opportunities for Research and Innovation”.

The EU has launched a “no holds barred” review of its ICT research and innovation strategy. But critics warn diverting R&D spending to problem areas such as energy and health will hold back ICT’s wider potential.

Financial incentives have attracted the Max Planck Society and an MIT lab to Florida. But can clusters be built on money alone?

A new report from Nesta shows that private money now accounts for only 43 per cent of early stage investments in the UK, leaving public funds to prop up innovation.

Three European cancer centres are joining forces to develop and implement innovative treatments and reduce treatment related side effects.